Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS)
CNY 62.27
(-1.16%)
CNY 62.27
(-1.16%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 110.85 Million CNY | 12.0% |
| 2022 | 98.97 Million CNY | 90.67% |
| 2021 | 51.91 Million CNY | 124.36% |
| 2020 | 23.13 Million CNY | 260.11% |
| 2019 | 6.42 Million CNY | 151.63% |
| 2018 | 2.55 Million CNY | 432.07% |
| 2017 | 479.9 Thousand CNY | 189.79% |
| 2016 | 165.6 Thousand CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 130.43 Million CNY | 17.66% |
| 2024 Q2 | 141.12 Million CNY | 8.2% |
| 2024 Q3 | 160.28 Million CNY | 13.58% |
| 2023 Q4 | 110.85 Million CNY | -3.43% |
| 2023 Q2 | 111.04 Million CNY | 11.75% |
| 2023 FY | 110.85 Million CNY | 12.0% |
| 2023 Q1 | 99.37 Million CNY | 0.4% |
| 2023 Q3 | 114.79 Million CNY | 3.37% |
| 2022 Q3 | 78.29 Million CNY | 11.14% |
| 2022 Q4 | 98.97 Million CNY | 26.42% |
| 2022 Q2 | 70.44 Million CNY | 9.77% |
| 2022 Q1 | 64.18 Million CNY | 23.63% |
| 2022 FY | 98.97 Million CNY | 90.67% |
| 2021 FY | 51.91 Million CNY | 124.36% |
| 2021 Q1 | 28.89 Million CNY | 24.89% |
| 2021 Q4 | 51.91 Million CNY | 6.38% |
| 2021 Q3 | 48.79 Million CNY | 25.91% |
| 2021 Q2 | 38.75 Million CNY | 34.12% |
| 2020 Q1 | 9.9 Million CNY | 54.12% |
| 2020 FY | 23.13 Million CNY | 260.11% |
| 2020 Q3 | 19.78 Million CNY | 53.73% |
| 2020 Q2 | 12.86 Million CNY | 29.96% |
| 2020 Q4 | 23.13 Million CNY | 16.95% |
| 2019 Q1 | 3.33 Million CNY | 30.42% |
| 2019 Q2 | 2.94 Million CNY | -11.49% |
| 2019 Q3 | 6.89 Million CNY | 133.94% |
| 2019 Q4 | 6.42 Million CNY | -6.82% |
| 2019 FY | 6.42 Million CNY | 151.63% |
| 2018 FY | 2.55 Million CNY | 432.07% |
| 2018 Q4 | 2.55 Million CNY | 0.0% |
| 2017 FY | 479.9 Thousand CNY | 189.79% |
| 2016 FY | 165.6 Thousand CNY | 0.0% |